Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio.
Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study